Bioness: Bioness Stockholders Challenge $110M Sale To Bioventus
An Israeli tech investor has opened a 10-count Delaware Chancery Court class challenge to orthopedic device maker Bioness Inc.'s $110 million acquisition by Bioventus Inc., alleging a low-ball, controller-orchestrated fire sale mainly arranged to benefit both the company's largest creditor and its buyer.
Read full article »
Bioness is a California-based medical device company that provides functional electrical stimulation and software-based therapy programs for central nervous system disorders.
Read more